Want to create an interactive transcript for this episode?
Podcast: Anesthesia Patient Safety Podcast
Episode: #250 Sugammadex in Special Populations: What Every Anesthesia Professional Needs to Know
Description: Sugammadex safety considerations span across patient populations with renal impairment, pediatric patients, and pregnant or breastfeeding individuals, requiring nuanced clinical decision-making based on current evidence and ongoing research.• Sugammadex reversal of moderate blockade is safe and faster than using neostigmine/cisatracurium for patients with renal impairment• Quantitative neuromuscular monitoring is essential to ensure adequate reversal (TOF >90%)• FDA approval exists for children 2+ years with the same dosing parameters as adults• Infants